Cronos Group Inc (NASDAQ:CRON) is one of the best CBD stocks to buy right now. The stock is up roughly 40% over the past year ...

The Canadian market has faced challenges recently, with first-quarter data indicating a technical recession amid ongoing inflation pressures. Despite these hurdles, the concept of penny stocks remains ...

Shares of Cronos Group (NASDAQ: CRON) were sinking 4.1% lower as of 10:57 a.m. ET on Tuesday and fell as much as 5.7% earlier in the day. The decline came after the U.S. Drug Enforcement ...

Cronos Group (NASDAQ: CRON) stock jumped 9.4% through 11:30 a.m. ET Tuesday after beating Wall Street forecasts for Q3 earnings this morning. Heading into the report, analysts expected Cronos to do ...

For its second quarter, Cronos -- which reports in U.S. dollars -- took in nearly $27.8 million in revenue, a figure almost 50% higher than the $19 million it earned in the same period of 2023. On a ...

For years, North American cannabis investors have endured a brutal hangover. Cronos Group (NASDAQ:CRON), once a darling of the 2018-2019 marijuana mania, watched its share price collapse more than 95% ...

View Cronos Group Inc CRON stock quote prices, financial information, real-time forecasts, and company news from CNN.

Tilray, Canopy Growth and Cronos are three US-listed names at the intersection of cannabis, wellness and beverages.

The average one-year price target for Cronos Group (NasdaqGM:CRON) has been revised to $3.79 / share. This is an increase of ...

TORONTO, March 16, 2026 (GLOBE NEWSWIRE)-- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, ...

Detailed price information for Cronos Group Inc (CRON-Q) from The Globe and Mail including charting and trades.